Eupraxia Pharmaceuticals (EPRX) Net Equity Issued and Repurchased (2023 - 2026)
Eupraxia Pharmaceuticals' Net Equity Issued and Repurchased was $49.25 million in Q2 2026, compared with $620,344 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eupraxia Pharmaceuticals' Net Equity Issued and Repurchased was $124.79 million through Jun 30, 2026, up 281.6% year-over-year; for FY2025, it came in at $76.06 million, up 38.5% from FY2024.
- Net Equity Issued and Repurchased shows a three-year compound annual growth rate of 90.8% (FY2022 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $54.92 million in FY2024 (+941.8%), $5.27 million in FY2023 (-51.8%) and $10.94 million in FY2022.
- Quarterly Net Equity Issued and Repurchased has moved between -$22.52 million (Q3 2024) and $75.42 million (Q4 2025) over five years.
- Per Business Quant data, EPRX's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $113,855 (Q1 2026), $75.42 million (Q4 2025) and $3,039 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.25 Mn |
| Mar 31, 2026 | 113,855.00 |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 73.26 Mn |
| Jun 30, 2025 | 620,344.00 |
| Mar 31, 2025 | 13,517.00 |
| Dec 31, 2024 | 54.58 Mn |
| Sep 30, 2024 | -22.52 Mn |
| Mar 31, 2024 | 22.85 Mn |
| Dec 31, 2023 | -10.61 Mn |
| Sep 30, 2023 | 11.07 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 229,536.00 |
API Access
Eupraxia Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();